Medical Research News

RSS

Young children use saliva sharing to understand close relationships

Young children, toddlers, and infants infer that individuals who share saliva through activities like kissing, sharing food or wiping drool are in so-called "thick" relationships – intimate bonds that people often share with family members.

21 Jan 2022

Intervention focusing on one's strength may be the best way to improve sad mood

What's the best way to improve a sad mood? It may be whatever skill you think you're best at, a new study suggests.

21 Jan 2022

Researchers transplant two kidneys from a genetically engineered pig into a brain-dead person

In a new study published in the American Journal of Transplantation, researchers report that they successfully transplanted two kidneys from a genetically modified pig into a human who was brain dead.

21 Jan 2022

Interactions that involve sharing saliva help babies to identify who has close relationships

Learning to navigate social relationships is a skill that is critical for surviving in human societies. For babies and young children, that means learning who they can count on to take care of them.

21 Jan 2022

Study investigates people's perceptions of COVID quarantine hotels during pandemic

As vaccination rates continue to rise and government border policies change, the need for hotel quarantine is fading.

21 Jan 2022

New study to help understand the effect of cancer medicine

When the muscles become acidic after doing too many press-ups, squats or cycling to work, it is because of lactic acid.

21 Jan 2022

New MRI technology to expand imaging access for patients with implanted medical devices and obesity

New MRI technology, developed by Siemens in collaboration with researchers at The Ohio State University College of Medicine and College of Engineering, will expand imaging access for patients with implanted medical devices, severe obesity and claustrophobia.

21 Jan 2022

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study, currently available on bioRxiv* preprint server, shows that a novel protease inhibitor known as nirmatrelvir has potent activity against Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in reducing the disease burden from coronavirus disease 2019 (COVID-19).

21 Jan 2022

Traumatic brain injury can lead to long-term visual impairment, finds study

Even mild head injuries can mean serious consequences for brain function at its most basic level. Research published in Communications Biology shows that neuroplasticity, too, has its limits.

21 Jan 2022

Study evaluates socio-economic burden imposed on Chinese healthcare system during COVID

In a recent study published in the journal Public Health, a research team from China has evaluated and presented the economic burden of public healthcare and hospitalization associated with COVID-19 in China.

20 Jan 2022

Using metal K-wires to hold broken wrist bones is not superior to traditional plaster cast

Using metal K-wires (commonly known as 'pins') to hold broken wrist bones in place while they heal are no better than a traditional molded plaster cast, finds a study published by The BMJ today.

20 Jan 2022

Human body relies on multiple maps based on the choice of motor system, research reveals

Our brain maps out our body to facilitate accurate motor control; disorders of this body map result in motor deficits.

20 Jan 2022

Researchers uncover new findings about the role of tau in neurodegenerative disease

Utilizing cutting-edge proteomics, researchers at the Buck Institute and elsewhere have mapped the "tau interactome" uncovering new findings about the role of tau in neurodegenerative disease. Publishing in Cell, scientists found that mutant tau impacts the function of mitochondria in human neurons.

20 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

Medical Research News

Young children use saliva sharing to understand close relationships

Intervention focusing on one's strength may be the best way to improve sad mood

Researchers transplant two kidneys from a genetically engineered pig into a brain-dead person

Interactions that involve sharing saliva help babies to identify who has close relationships

Study investigates people's perceptions of COVID quarantine hotels during pandemic

New study to help understand the effect of cancer medicine

New MRI technology to expand imaging access for patients with implanted medical devices and obesity

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

Traumatic brain injury can lead to long-term visual impairment, finds study

Study evaluates socio-economic burden imposed on Chinese healthcare system during COVID

Using metal K-wires to hold broken wrist bones is not superior to traditional plaster cast

Human body relies on multiple maps based on the choice of motor system, research reveals

Researchers uncover new findings about the role of tau in neurodegenerative disease

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

A validated risk-stratification system to manage COVID-19 outpatients

Indian study suggests significant decrease in protection from vaccine or natural immunity against Omicron variant

Research shows benefits of hybrid immunity to SARS-CoV-2

NIH-funded study will use machine learning to predict individual responses to diet

Oral supplement appears to promote muscle endurance and mitochondrial health in humans

Study findings could help guide treatment planning for men with high-risk prostate cancer

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News